United Therapeutics Corporation
UTHR | NASDAQ
$491.80
-$1.30 (-0.26%)
Sep 22, 2026, 10:34 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 607.9M | 274.9M | 364.3M | 338.7M | 309.5M | 322.2M | 301.3M | 309.1M | 278.1M | 306.6M | 217.1M | 267.6M | 259.2M | 240.9M | 132.1M | 239.3M | 116M | 239.9M | 112.2M | 162.7M | 172.6M | 28.3M |
Depreciation & Amortization | 46.8M | 22.6M | 22.8M | 21.9M | 21.1M | 19.8M | 19.7M | 19.1M | 18.7M | 15M | 13.7M | 13.3M | 12.9M | 13.3M | 13.2M | 12.9M | 12.7M | 12.5M | 12.6M | 12.4M | 12.4M | 12.5M |
Stock-Based Compensation | 77.3M | n/a | 39M | 39.1M | 37.8M | 31.8M | 27M | 41.7M | 49.7M | 25.6M | 16.6M | 21.1M | 13.8M | -12.4M | 64.8M | -2.4M | 65.5M | -21.1M | 44.7M | 24.6M | 29.1M | 40.1M |
Other Working Capital | -77.1M | 27M | -141.7M | 67.2M | -138.3M | 131.9M | -55.1M | 75.4M | -110.6M | 77.4M | -64.4M | 35.1M | -40.2M | 43.8M | -85.2M | 51.6M | -106.6M | 34.1M | -47.1M | 1.2M | -44.3M | -35.2M |
Other Non-Cash Items | 105M | 127.5M | -33.6M | -100K | 26.3M | 9.4M | -2.6M | -5.7M | -5.5M | -10.5M | -5M | -1.8M | -300K | 5.8M | 5.9M | 16.1M | 46.8M | -10.5M | 38.2M | 32.2M | 7.8M | 30M |
Deferred Income Tax | 51.6M | 25.9M | 97.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -111.7M | 12.4M | -143.9M | 162.5M | -203M | 78M | -4.2M | 13M | -108.8M | 39.8M | -91.7M | 46M | -179.3M | 127.2M | -87.8M | -7.3M | -114M | 67.9M | -33.1M | -46.3M | -73.7M | -21.1M |
Operating Cash Flow | 776.9M | 463.3M | 346.2M | 562.1M | 191.7M | 461.2M | 341.2M | 377.2M | 232.2M | 376.5M | 150.7M | 346.2M | 106.3M | 374.8M | 128.2M | 258.6M | 127M | 288.7M | 174.6M | 185.6M | 148.2M | 89.8M |
Capital Expenditures | -208.8M | -100.8M | -172.9M | -210.5M | -62.2M | -74.9M | -86.7M | -76.5M | -45.1M | -38.2M | -78.7M | -65.7M | -44.7M | -41.3M | -39.5M | -68.8M | -17M | -13.5M | -70.6M | -23.3M | -16.3M | -10.6M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -30M | n/a | n/a | n/a | -89.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -795.8M | -726.7M | -545.3M | -415.9M | -1.81B | -692.3M | -478.5M | -407.8M | -230.5M | -529.3M | -308M | -644.8M | -672M | -889.5M | -430.5M | -270M | -530.5M | -477.6M | -496.9M | -529M | -310.4M | -559M |
Sales Maturities Of Investments | 1.84B | 1.58B | -780.1M | 182.5M | 1.57B | 611.7M | 478M | 387.2M | 196.5M | 1.31B | 526.7M | 407.7M | 493.2M | 709.7M | 277.2M | 246.3M | 378.5M | 131.9M | 371.7M | 308.6M | 285.6M | 563.3M |
Other Investing Acitivies | -6.4M | -5.7M | 1.27B | 584.8M | -600K | -9.2M | -6M | -17.8M | -900K | -4.3M | -8.7M | -10.6M | -3.7M | n/a | 3.5M | -1.5M | n/a | n/a | n/a | 7.8M | -7.8M | n/a |
Investing Cash Flow | 831.2M | 743.7M | -227.6M | 140.9M | -299.9M | -164.7M | -123.2M | -114.9M | -80M | 735.3M | 42.1M | -313.4M | -227.2M | -221.1M | -189.3M | -94M | -169M | -359.2M | -195.8M | -235.9M | -48.9M | -6.3M |
Debt Repayment | n/a | n/a | 11.5M | n/a | -211.5M | -100M | -100M | -100M | -100M | -100M | -100M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -1.5B | -1.5B | n/a | -1B | n/a | n/a | -300K | -400K | -11.5M | -1B | -100K | -200K | -13.5M | -13.5M | n/a | -300K | n/a | -11.1M | -200K | -200K | -200K | -10.2M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -62.2M | -58.3M | -33.6M | -500K | -5.2M | -15.3M | 25.6M | 36.3M | 63.5M | 32M | 7.3M | 7.8M | 38.2M | 62.1M | 55.5M | 7.3M | n/a | 100K | 7.7M | 16.8M | 10.8M | 20.3M |
Financial Cash Flow | -1.36B | -1.48B | 98.4M | -956M | -198.6M | -93.8M | -74.7M | -64.1M | -48M | -1.07B | -92.8M | 7.6M | 24.7M | 48.6M | 55.5M | 7M | 23.9M | -11M | 7.5M | 16.6M | 10.6M | 10.1M |
Net Cash Flow | 246.1M | -482.9M | 217M | -253M | -306.8M | 202.7M | 143.3M | 198.2M | 104.2M | 43.8M | 100M | 40.4M | -96.2M | 202.3M | -5.6M | 171.6M | -18.1M | -81.5M | -13.7M | -33.7M | 109.9M | 93.6M |
Free Cash Flow | 568.1M | 362.5M | 173.3M | 351.6M | 129.5M | 386.3M | 254.5M | 300.7M | 187.1M | 338.3M | 72M | 280.5M | 61.6M | 333.5M | 88.7M | 189.8M | 110M | 275.2M | 104M | 162.3M | 131.9M | 79.2M |
Adj. Free Cash Flow | 490.8M | 362.5M | 134.3M | 312.5M | 91.7M | 354.5M | 227.5M | 259M | 137.4M | 312.7M | 55.4M | 259.4M | 47.8M | 345.9M | 23.9M | 192.2M | 44.5M | 296.3M | 59.3M | 137.7M | 102.8M | 39.1M |
Maintenance CapEx | -46.8M | -22.6M | -147.06M | -186.42M | -22.37M | -19.37M | -31.65M | -13.14M | n/a | n/a | -24.29M | -24.45M | n/a | -21.43M | -7.36M | -38.76M | -8.41M | n/a | -58.3M | n/a | n/a | -1.34M |
Growth CapEx | -162M | -78.2M | -25.84M | -24.08M | -39.83M | -55.53M | -55.05M | -63.36M | -45.1M | -38.2M | -54.41M | -41.25M | -44.7M | -19.87M | -32.14M | -30.04M | -8.59M | -13.5M | -12.3M | -23.3M | -16.3M | -9.26M |
Owner Earnings | 730.1M | 440.7M | 199.14M | 375.68M | 169.33M | 441.83M | 309.55M | 364.06M | 232.2M | 376.5M | 126.41M | 321.75M | 106.3M | 353.37M | 120.84M | 219.84M | 118.59M | 288.7M | 116.3M | 185.6M | 148.2M | 88.46M |
Add to Watchlist
Select watchlists to add or remove UTHR